INDUSTRY COMPONENT

Counterion

Counterion is a charged component used to stabilize active pharmaceutical ingredients by forming ionic complexes.

View Specifications

Component Specifications

Definition
In pharmaceutical-grade API manufacturing, a counterion is an oppositely charged ion that pairs with an ionizable active pharmaceutical ingredient to form a stable salt or complex. This component is critical for controlling solubility, stability, bioavailability, and crystallization properties of APIs. Counterions are selected based on their ability to enhance pharmaceutical performance while maintaining safety and regulatory compliance.
Working Principle
Counterions work through ionic bonding principles, where positively charged cations pair with negatively charged API anions (or vice versa) to form neutral salts. This interaction modifies the API's physical-chemical properties, including melting point, hygroscopicity, and dissolution rate. The selection follows the hard-soft acid-base theory and considers ionic radius, charge density, and hydration energy to achieve optimal pharmaceutical characteristics.
Materials
Pharmaceutical-grade inorganic or organic ions including sodium, potassium, calcium, magnesium, chloride, sulfate, phosphate, citrate, tartrate, mesylate, besylate, or custom organic anions. Materials must meet USP/EP/JP pharmacopeia standards for purity (<0.1% impurities) and be free from heavy metals, residual solvents, and microbial contamination.
Technical Parameters
  • Purity ≥99.9%
  • pH Range 5.0-8.0 in 1% solution
  • Heavy Metals <10 ppm
  • Particle Size 10-100 μm
  • Microbial Limits <100 CFU/g
  • Moisture Content <0.5%
  • Residual Solvents Class 1: <10 ppm, Class 2: <100 ppm
Standards
ISO 9001, ISO 13485, USP <467>, ICH Q3D, EP 2.4.16

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Counterion.

pharmaceutical counterion API stabilization ionic complexes pharmaceutical salts drug formulation components GMP compliance Counterion Counterion in Chemical Manufacturing

Parent Products

This component is used in the following industrial products

Pharmaceutical-Grade Active Pharmaceutical Ingredient (API)

Pure chemical substance responsible for therapeutic effect in pharmaceutical formulations

View Product Details

Engineering Analysis

Risks & Mitigation
  • Ionic imbalance affecting API stability
  • Counterion degradation during processing
  • Regulatory non-compliance due to impurity profiles
  • Batch-to-batch variability in complex formation
FMEA Triads
Trigger: Incorrect stoichiometric ratio during salt formation
Failure: Incomplete complexation leading to API degradation
Mitigation: Implement real-time pH monitoring and automated dosing controls with ±0.5% accuracy
Trigger: Counterion hygroscopicity exceeding specifications
Failure: Moisture absorption affecting powder flow and tablet compression
Mitigation: Use desiccant packaging and controlled humidity environments (<30% RH) during storage

Industrial Ecosystem

Compatible With

Interchangeable Parts

Compliance & Inspection

Tolerance
±0.1% for ionic concentration, ±5% for particle size distribution
Test Method
HPLC for purity, ICP-MS for elemental analysis, Karl Fischer for moisture, USP <701> for dissolution

Procurement Evaluation Criteria

Not customer reviews or live demand data. These dimensions support RFQ preparation and supplier evaluation.

Technical documentation
4/5
Manufacturing capability
4/5
Inspection readiness
5/5
Supplier transparency
3/5

These scores are example evaluation dimensions, not real customer ratings, country-specific buyer feedback, or live inquiry activity.

Related Components

Seeding Port
A precision port for introducing seed crystals into batch crystallization systems to initiate controlled crystal growth.
Sight Glass
A transparent window for visual inspection of fluid flow and crystallization processes in industrial systems.
Control Software
Specialized software for real-time monitoring and control of continuous flow pharmaceutical reactors, ensuring precise process parameters and regulatory compliance.
Conveyor Interface
Precision interface component connecting vial transport systems in pharmaceutical inspection machines

Frequently Asked Questions

What factors determine counterion selection in API manufacturing?

Selection is based on API pKa, desired solubility profile, stability requirements, bioavailability targets, regulatory acceptance, and manufacturing process compatibility. Common considerations include ionic strength, hygroscopicity, and crystallization behavior.

How do counterions affect drug bioavailability?

Counterions modify dissolution rates, permeability, and metabolic pathways. Optimal pairing can enhance oral absorption by 20-50% through improved solubility and membrane transport properties while maintaining therapeutic efficacy.

Can I contact factories directly?

Yes, each factory profile provides direct contact information.

Data Basis

CNFX manufacturer profiles, technical classification, publicly available product information, and ongoing plausibility checks.

Preliminary Technical Classification
This page supports structured research, RFQ preparation, and supplier evaluation. It does not replace buyer-led supplier qualification, standards review, or technical approval.

Request Manufacturing Insight for Counterion

Corrosion Liner/Cladding Cross bars